Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Allergan plc (NYSE:AGN)

331.15
Delayed Data
As of Jul 31
 +2.28 / +0.69%
Today’s Change
201.91
Today|||52-Week Range
340.34
+28.65%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Operating ActivitiesNet Income / Starting Line48.8M-1.0B-732.9M-512.3M
 
 
 
 
 
Depreciation472.4M938.2M938.0M982.6M
 
 
 
 
 
Total Other Cash Flow190.6M979.1M861.7M781.0M
 
 
 
 
 
Funds From Operations710.2M613.5M789.2M947.0M
 
 
 
 
 
Funds From/For Other Operating Expenses240.7M91.2M-22.4M422.0M
 
 
 
 
 
Net Cash Flow - Operating Activities469.5M522.3M811.6M525.0M
 
 
 
 
 
 
InvestingIncrease In Investments0.000.00-1.0M-15.0M
 
 
 
Decrease In Investments-15.0M1.5M10.5M--
 
 
 
 
Capital Expenditures-38.3M-93.3M-64.5M-136.6M
 
 
 
 
 
Fixed Asset Disposal800.0K7.8M1.7M74.9M
 
 
 
 
 
Net Assets From Acquisitions -119.2M-4.8B-639.7M-34.6B
 
 
 
 
 
Other Investing - Sources18.0M433.2M-9.5M790.5M
 
 
 
 
 
Net Cash Flow Investing-153.7M-4.5B-738.5M-33.9B
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.00----
Long Term Borrowings3.7B4.4B1.0B29.0B
 
 
 
 
 
Long Term Debt Reduction-141.7M-4.4B-1.3B-2.7B
 
 
 
 
 
Net Proceeds Stock Sale1.7M35.2M62.6M9.0B
 
 
 
 
 
Common Preferred Redeemed-2.4M-40.3M-30.4M-64.1M
 
 
 
 
 
Common Dividends----------
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing-14.1M0.0028.4M36.1M
 
 
 
 
Other Uses - Financing0.004.8M1.7M24.6M
 
 
 
 
Net Cash Flow - Financing3.6B-23.9M-158.7M35.3B
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-1.9M1.7M-3.8M-4.8M
 
 
 
 
 
 
Net Change In Cash3.9B-4.0B-85.6M1.9B